Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timoptic-XE for chronic diabetic foot ulcers
NCT03282981Phase 3Completed
- Sponsor
- VA Office of Research & Development
- Start
- Jul 2018
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of timolol in diabetic foot ulcer (DFU), sponsored by VA Office of Research & Development. Started Jul 2018; status: completed.
02
Drugs
timolol
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT03282981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03282981.